Precipio (NASDAQ:PRPO) dropped 6.2% on Thursday . The stock traded as low as $6.62 and last traded at $6.69. Approximately 611,647 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 870,787 shares. The stock had previously closed at $7.13.
The company has a quick ratio of 0.12, a current ratio of 0.13 and a debt-to-equity ratio of 0.07.
TRADEMARK VIOLATION WARNING: “Precipio (PRPO) Trading Down 6.2%” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.chaffeybreeze.com/2019/05/18/precipio-prpo-trading-down-6-2.html.
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Recommended Story: Put Option
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.